Spots Global Cancer Trial Database for haematological malignancy
Every month we try and update this database with for haematological malignancy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation | NCT03146468 | Haematological ... | Nivolumab Injec... | 18 Years - | Melbourne Health | |
| Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological Malignancy | NCT05379738 | Haematological ... | 6 sessions of a... | 18 Years - | Centre Hospitalier Universitaire de Nice | |
| Cognitive Status Assessment In Elderly Patients With Active Treatment For Haematological Malignancies | NCT04673305 | Cognitive Impai... Haematological ... Chemo-brain | Cognitive Asses... | 70 Years - 90 Years | Ospedale San Carlo Borromeo | |
| Impact of Oral Nutritional Supplements on Patients Undergoing Haematopoietic Stem Cell Transplantation | NCT05460013 | Haematological ... | Traditional Con... Oral Nutritiona... | 18 Years - 75 Years | RenJi Hospital | |
| Study to Evaluate CCS1477 in Haematological Malignancies | NCT04068597 | Haematological ... Acute Myeloid L... Non Hodgkin Lym... Multiple Myelom... Higher-risk Mye... Peripheral T Ce... | CCS1477 Pomalidomide Dexamethasone Azacitidine Venetoclax | 18 Years - | CellCentric Ltd. | |
| Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation | NCT06395220 | Haematological ... | Detection of do... | 15 Years - 60 Years | Peking University People's Hospital | |
| Economic Evaluation of Innovative Molecular Analyses in Onco-haematology | NCT03750994 | Haematological ... | - | Assistance Publique - Hôpitaux de Paris | ||
| DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. | NCT05770544 | Solid Tumor Haematological ... Malignancy Malignant Neopl... Lymphoprolifera... Neoplasms by Hi... Neoplasms by Si... Cancer Brain Neoplasms Melanoma Glioma | Entrectinib | - | Cancer Research UK | |
| Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies | NCT04298892 | Haematologic Di... Haematological ... | clinical data a... | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Central Venous Access Device Removal in Cancer Patients | NCT03855969 | Oncology Haematological ... | Removal of a ce... | - | General Hospital Groeninge | |
| Total Marrow Irradiation With Volumetric Arc Therapy for Patients Unfit for a 12 Gy TBI | NCT03262220 | Haematological ... | Volumetric Arc ... | 40 Years - 80 Years | University Hospital, Geneva | |
| Remote Monitoring of Cancer Patients With Suspected Covid-19 | NCT04397705 | COVID Oncology Haematological ... | Patient Status ... | 18 Years - | The Christie NHS Foundation Trust | |
| A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms | NCT02842229 | Myelodysplastic... Leukemia Myeloi... Multiple Myelom... Leukemia, Lymph... | 65 Years - | Celgene | ||
| Economic Evaluation of Innovative Molecular Analyses in Onco-haematology | NCT03750994 | Haematological ... | - | Assistance Publique - Hôpitaux de Paris | ||
| Early Palliative Care for Patients With Haematological Malignancies | NCT03800095 | Acute Myeloid L... Myelodysplastic... Diffuse Large B... Palliative Care | Early palliativ... | 70 Years - | University Hospital, Clermont-Ferrand | |
| Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies | NCT05148806 | Solid Organ Tra... Autoimmune Dise... Haematological ... | self-administer... | 12 Years - | Imperial College London | |
| A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts | NCT04331483 | Haematological ... Acute Leukemia Myelodysplastic... Hemoglobinopath... Bone Marrow Apl... Severe Combined... | Physical activi... | 8 Years - 21 Years | Centre Leon Berard | |
| A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts | NCT04331483 | Haematological ... Acute Leukemia Myelodysplastic... Hemoglobinopath... Bone Marrow Apl... Severe Combined... | Physical activi... | 8 Years - 21 Years | Centre Leon Berard | |
| Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological Malignancy | NCT05379738 | Haematological ... | 6 sessions of a... | 18 Years - | Centre Hospitalier Universitaire de Nice | |
| Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey. | NCT05352789 | Haematological ... Bone Marrow Tra... Stem Cell Trans... Nutrition Aspec... Nutritional and... Exercise Interv... Prehabilitation | Non validated S... | 18 Years - | Nottingham University Hospitals NHS Trust | |
| DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. | NCT05768178 | Solid Tumor Haematological ... Melanoma Thyroid Cancer,... Ovarian Neoplas... Colorectal Neop... Laryngeal Neopl... Carcinoma, Non-... Glioma Multiple Myelom... Erdheim-Chester... Thyroid Carcino... | Vemurafenib Cobimetinib | 18 Years - | Cancer Research UK | |
| Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers | NCT05302037 | Cancer Malignancy Refractory Canc... Relapsed Cancer | Allogeneic NKG2... | 21 Years - | CytoMed Therapeutics Pte Ltd | |
| Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers | NCT01597219 | Hodgkin's Lymph... Non-Hodgkin's L... Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Chronic Myeloid... Chronic Lymphoc... Acquired Bone M... Other Haematolo... | Reduced intensi... Myeloablative h... | 16 Years - 70 Years | University College, London | |
| Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies | NCT02164071 | Myelodysplastic... Leukemia Myeloi... Multiple Myelom... Leuklemia, Lymp... | Geriatric Asses... | 65 Years - | Celgene | |
| Hématologie Adulte Prevalence of Adrenal Insufficiency Post-chemotherapy Adrenocorticotropia in Adult Hematology | NCT03688789 | Haematological ... | Hydrocortisone ... | 18 Years - | Rennes University Hospital | |
| Nutrition Health Literacy of Cancer Patients and Their Support Networks. | NCT03978312 | Cancer Oncologic Disor... Haematological ... Nutrition Aspec... | Nominal consens... Observational c... | 18 Years - | Nottingham University Hospitals NHS Trust | |
| Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation | NCT05298930 | Haematological ... Acute Leukemia Myelodysplastic... Hemoglobinopath... Bone Marrow Apl... Severe Combined... | Physical activi... | 8 Years - 21 Years | Centre Leon Berard | |
| Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment | NCT05695638 | Solid Tumor, Un... Haematological ... | 18 Years - | Aalborg University Hospital | ||
| Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey. | NCT05352789 | Haematological ... Bone Marrow Tra... Stem Cell Trans... Nutrition Aspec... Nutritional and... Exercise Interv... Prehabilitation | Non validated S... | 18 Years - | Nottingham University Hospitals NHS Trust | |
| Early Palliative Care for Patients With Haematological Malignancies | NCT03800095 | Acute Myeloid L... Myelodysplastic... Diffuse Large B... Palliative Care | Early palliativ... | 70 Years - | University Hospital, Clermont-Ferrand | |
| The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs | NCT05159245 | Advanced Cancer Solid Tumor Haematological ... | Alectinib Cobimetinib Vismodegib Trastuzumab+Per... Entrectinib Atezolizumab Vemurafenib Regorafenib Apalutamide Abemaciclib Selpercatinib Dabrafenib Trametinib Dabrafenib+Tram... Pralsetinib | 18 Years - 100 Years | Helsinki University Central Hospital | |
| Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies | NCT02164071 | Myelodysplastic... Leukemia Myeloi... Multiple Myelom... Leuklemia, Lymp... | Geriatric Asses... | 65 Years - | Celgene | |
| Concordance Between 2 Means of Temperature Measure in Neutropenic Patients Hospitalized in Intensive Hematology Care Units | NCT04174053 | Haematological ... | Enteric capsule | 18 Years - | Centre Henri Becquerel | |
| Rehabilitation Needs of the Malaysian Haematological Cancer Survivors | NCT04236063 | Haematological ... Leukemia, Acute Lymphoma Myeloma Multipl... Blood Cancer Quality of Life | WHODAS 2.0 Ques... | 18 Years - 80 Years | University of Malaya | |
| Rehabilitation Needs of the Malaysian Haematological Cancer Survivors | NCT04236063 | Haematological ... Leukemia, Acute Lymphoma Myeloma Multipl... Blood Cancer Quality of Life | WHODAS 2.0 Ques... | 18 Years - 80 Years | University of Malaya | |
| Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological Malignancy | NCT05379738 | Haematological ... | 6 sessions of a... | 18 Years - | Centre Hospitalier Universitaire de Nice | |
| Hématologie Adulte Prevalence of Adrenal Insufficiency Post-chemotherapy Adrenocorticotropia in Adult Hematology | NCT03688789 | Haematological ... | Hydrocortisone ... | 18 Years - | Rennes University Hospital | |
| DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. | NCT05770544 | Solid Tumor Haematological ... Malignancy Malignant Neopl... Lymphoprolifera... Neoplasms by Hi... Neoplasms by Si... Cancer Brain Neoplasms Melanoma Glioma | Entrectinib | - | Cancer Research UK | |
| Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies | NCT05203809 | Haematological ... Leukemia Lymphoma Myeloma Temperature Cha... | TempTraq temper... | 16 Years - 75 Years | Malaghan Institute of Medical Research | |
| Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies | NCT04298892 | Haematologic Di... Haematological ... | clinical data a... | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment | NCT05695638 | Solid Tumor, Un... Haematological ... | 18 Years - | Aalborg University Hospital | ||
| A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms | NCT02842229 | Myelodysplastic... Leukemia Myeloi... Multiple Myelom... Leukemia, Lymph... | 65 Years - | Celgene | ||
| A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms | NCT02842229 | Myelodysplastic... Leukemia Myeloi... Multiple Myelom... Leukemia, Lymph... | 65 Years - | Celgene | ||
| Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient | NCT03806764 | Cytomegalovirus... Haematological ... Organ or Tissue... Immune Suppress... | Blood sampling | 18 Years - | Melbourne Health | |
| Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment | NCT05695638 | Solid Tumor, Un... Haematological ... | 18 Years - | Aalborg University Hospital | ||
| Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies | NCT05148806 | Solid Organ Tra... Autoimmune Dise... Haematological ... | self-administer... | 12 Years - | Imperial College London | |
| Central Venous Access Device Removal in Cancer Patients | NCT03855969 | Oncology Haematological ... | Removal of a ce... | - | General Hospital Groeninge | |
| oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort | NCT05170347 | Graft Vs Host D... Haematological ... Cancer | 18 Years - | The University of Hong Kong |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
